Key result
Continuing versus discontinuing chronic anticoagulation during cardiac device surgeries will be assessed for benefits and harms in this Cochrane Review protocol.
Why the study?
To evaluate the benefits and harms of continuing versus discontinuing chronic anticoagulation in the perioperative period of CIED surgeries.
Does continuing chronic anticoagulation improve outcomes compared to discontinuing anticoagulation in patients undergoing CIED surgeries?
Does continuing chronic anticoagulation improve outcomes compared to discontinuing anticoagulation in patients undergoing CIED surgeries?
This is a protocol for a Cochrane Review to evaluate the safety and efficacy of uninterrupted versus interrupted anticoagulation during CIED surgeries.
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of continuing chronic anticoagulation with either warfarin or a direct oral anticoagulant in the perioperative period of CIED surgeries versus discontinuing anticoagulation with or without heparin bridging during an equivalent timeframe for CIED surgeries.
No takes yet. Share an insight, caveat, or question.
Hernández et al. (2020) studied this question. Continuing versus discontinuing chronic anticoagulation during cardiac device surgeries will be assessed for benefits and harms in this Cochrane Review protocol.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: